CXCL8 (IL-8), an inflammatory chemokine originally discovered as the neutrophil chemoattractant and inducer of leukocyte-mediated inflammation [1,2,3], contributes to cancer progression through its induction of tumor cell proliferation, migration and angiogenesis [4,5,6,7,8,9]. The gene discussed is CXCL8; the disease is cancer.